Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1995-02

AUTHORS

P A Ellis, I E Smith, J R Hardy, M C Nicolson, D C Talbot, S E Ashley, K Priest

ABSTRACT

The role of chemotherapy in the palliation of patients with advanced stage (IIIB and IV non-small-cell lung cancer (NSCLC) remains controversial. We have carried out a chemotherapy study emphasising symptom relief, a topic not normally discussed in previous similar studies. A total of 120 patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) were treated with a moderate-dose palliative chemotherapy regimen consisting of mitomycin C 8 mg m-2 i.v. on day 1 (alternate courses), vinblastine 6 mg m-2 i.v. on day 1 and cisplatin 50 mg m-2 i.v. on day 1 (MVP), repeating every 21 days for a maximum of six courses. Thirty-eight of 118 assessable patients (32%) achieved an objective response. Patients with locally advanced disease (stage IIIB) had a significantly better response rate (52%) than those with metastatic disease (25%) (P < 0.01). In 76 out of 110 (69%) patients, with tumour-related symptoms including 24 out of 31 patients (78%) with locally advanced disease, symptoms completely disappeared or substantially improved. In only 15 patients (14%) did symptoms progress during treatment. Symptomatic improvement was achieved after one course of chemotherapy in 61% and after two courses in 96% of responding patients. The schedule was well tolerated. Only 19% developed WHO grade 3/4 nausea/vomiting, and only 3% developed significant alopecia. Other toxicities were minimal. MVP is a pragmatic inexpensive chemotherapy regimen that offers useful symptom palliation in patients with advanced NSCLC and merits a 1-2 course therapeutic trial in such patients. The schedule should also be assessed as primary (neoadjuvant) chemotherapy before radical radiotherapy for locally advanced NSCLC in a randomised trial. More... »

PAGES

366

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1995.74

DOI

http://dx.doi.org/10.1038/bjc.1995.74

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039124507

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7530988


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alopecia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematologic Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitomycins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nausea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Palliative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vinblastine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vomiting", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Royal Marsden Hospital", 
          "id": "https://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Lung Unit, Royal Marsden Hospital, Sutton, Surrey, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ellis", 
        "givenName": "P A", 
        "id": "sg:person.01222317235.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222317235.09"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Smith", 
        "givenName": "I E", 
        "id": "sg:person.016301514162.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016301514162.37"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Hardy", 
        "givenName": "J R", 
        "id": "sg:person.01203477301.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203477301.58"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Nicolson", 
        "givenName": "M C", 
        "id": "sg:person.01203740575.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203740575.36"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Talbot", 
        "givenName": "D C", 
        "id": "sg:person.01116057764.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116057764.83"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ashley", 
        "givenName": "S E", 
        "id": "sg:person.016652536532.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016652536532.25"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Priest", 
        "givenName": "K", 
        "id": "sg:person.0762233040.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762233040.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1990.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000556360", 
          "https://doi.org/10.1038/bjc.1990.135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000556360", 
          "https://doi.org/10.1038/bjc.1990.135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1988.219", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001336530", 
          "https://doi.org/10.1038/bjc.1988.219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1988.219", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001336530", 
          "https://doi.org/10.1038/bjc.1988.219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19910515)67:10<2443::aid-cncr2820671008>3.0.co;2-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008273687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0169-5002(91)90279-f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011284989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199010043231403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016764914"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0169-5002(93)90173-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020528345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)91882-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024077091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)91882-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024077091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.90.2.229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026608030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-198810000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028675398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-198810000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028675398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.355", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031243548", 
          "https://doi.org/10.1038/bjc.1989.355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.355", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031243548", 
          "https://doi.org/10.1038/bjc.1989.355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19820901)50:5<845::aid-cncr2820500507>3.0.co;2-s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046751381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049278910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.89.4_supplement.225s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051695750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051988897"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/83.6.417", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059817056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/85.10.794", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059817925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-115-9-681", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073696110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-95-4-414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073738990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.5.886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078398349"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.8.1301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078408611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1988.6.4.633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079416239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079510178", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1986.4.12.1780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079511932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1986.4.1.14", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079793348"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-02", 
    "datePublishedReg": "1995-02-01", 
    "description": "The role of chemotherapy in the palliation of patients with advanced stage (IIIB and IV non-small-cell lung cancer (NSCLC) remains controversial. We have carried out a chemotherapy study emphasising symptom relief, a topic not normally discussed in previous similar studies. A total of 120 patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) were treated with a moderate-dose palliative chemotherapy regimen consisting of mitomycin C 8 mg m-2 i.v. on day 1 (alternate courses), vinblastine 6 mg m-2 i.v. on day 1 and cisplatin 50 mg m-2 i.v. on day 1 (MVP), repeating every 21 days for a maximum of six courses. Thirty-eight of 118 assessable patients (32%) achieved an objective response. Patients with locally advanced disease (stage IIIB) had a significantly better response rate (52%) than those with metastatic disease (25%) (P < 0.01). In 76 out of 110 (69%) patients, with tumour-related symptoms including 24 out of 31 patients (78%) with locally advanced disease, symptoms completely disappeared or substantially improved. In only 15 patients (14%) did symptoms progress during treatment. Symptomatic improvement was achieved after one course of chemotherapy in 61% and after two courses in 96% of responding patients. The schedule was well tolerated. Only 19% developed WHO grade 3/4 nausea/vomiting, and only 3% developed significant alopecia. Other toxicities were minimal. MVP is a pragmatic inexpensive chemotherapy regimen that offers useful symptom palliation in patients with advanced NSCLC and merits a 1-2 course therapeutic trial in such patients. The schedule should also be assessed as primary (neoadjuvant) chemotherapy before radical radiotherapy for locally advanced NSCLC in a randomised trial.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1995.74", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "71"
      }
    ], 
    "name": "Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer", 
    "pagination": "366", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ba5e9711020e195ce2e7b7f819c670085e111a1c2976675d4f6d0525ff9a8561"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7530988"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1995.74"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039124507"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1995.74", 
      "https://app.dimensions.ai/details/publication/pub.1039124507"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29212_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc199574"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1995.74'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1995.74'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1995.74'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1995.74'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      75 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1995.74 schema:about N113b1a621b584250aa24218b7e59c506
2 N13ebfc5c5d3c4b47adae3c03ad9d8453
3 N2bccdd607c4b4abcafd11fb0fd7f92c2
4 N399ec8867562470d96eae254da142444
5 N46b343b1d6a4483c9ce352fa457e6ff6
6 N64571c07d8e841fb8baa4bc163b1a972
7 N787218321954447ea716d60133cdd42e
8 N83552de71a564812b9bb80b7853ec280
9 N89830eee316d4de5b8b1c9f9413e68c0
10 N8d632052c93e466188e34db4df6fbfa6
11 N8f6e73efe50543edafc6b68d1d48ca80
12 N93b2c79b234147cfbb71945bed71a925
13 N9ee5a200ea9444048309f577a8ebd259
14 Na1c0568db4284ec3ac879dcbe40d723d
15 Na5407793803047c5aca48647d3102cf0
16 Nadb6a5b59c594422a2fa01f3285c4220
17 Nb06e5697b09048908f2145022c2aa7ef
18 Nce5ab3e5a5ec4d78958ea676cf62963c
19 Ndbecfca17de440e5acc4357a8f8aab0c
20 Ne7c14b33ee874a038b3667641be7c519
21 Nf62e27b0a5bb46c79664d7cfa492cae6
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N4233f395b7c642eea1f5367adf1ac47f
25 schema:citation sg:pub.10.1038/bjc.1988.219
26 sg:pub.10.1038/bjc.1989.355
27 sg:pub.10.1038/bjc.1990.135
28 https://app.dimensions.ai/details/publication/pub.1079510178
29 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6
30 https://doi.org/10.1002/1097-0142(19820901)50:5<845::aid-cncr2820500507>3.0.co;2-s
31 https://doi.org/10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6
32 https://doi.org/10.1002/1097-0142(19910515)67:10<2443::aid-cncr2820671008>3.0.co;2-k
33 https://doi.org/10.1016/0140-6736(93)91882-m
34 https://doi.org/10.1016/0169-5002(91)90279-f
35 https://doi.org/10.1016/0169-5002(93)90173-u
36 https://doi.org/10.1056/nejm199010043231403
37 https://doi.org/10.1080/01621459.1958.10501452
38 https://doi.org/10.1093/jnci/83.6.417
39 https://doi.org/10.1093/jnci/85.10.794
40 https://doi.org/10.1097/00000421-198810000-00012
41 https://doi.org/10.1200/jco.1986.4.1.14
42 https://doi.org/10.1200/jco.1986.4.12.1780
43 https://doi.org/10.1200/jco.1988.6.4.633
44 https://doi.org/10.1200/jco.1990.8.5.886
45 https://doi.org/10.1200/jco.1990.8.8.1301
46 https://doi.org/10.1378/chest.89.4_supplement.225s
47 https://doi.org/10.1378/chest.90.2.229
48 https://doi.org/10.7326/0003-4819-115-9-681
49 https://doi.org/10.7326/0003-4819-95-4-414
50 schema:datePublished 1995-02
51 schema:datePublishedReg 1995-02-01
52 schema:description The role of chemotherapy in the palliation of patients with advanced stage (IIIB and IV non-small-cell lung cancer (NSCLC) remains controversial. We have carried out a chemotherapy study emphasising symptom relief, a topic not normally discussed in previous similar studies. A total of 120 patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) were treated with a moderate-dose palliative chemotherapy regimen consisting of mitomycin C 8 mg m-2 i.v. on day 1 (alternate courses), vinblastine 6 mg m-2 i.v. on day 1 and cisplatin 50 mg m-2 i.v. on day 1 (MVP), repeating every 21 days for a maximum of six courses. Thirty-eight of 118 assessable patients (32%) achieved an objective response. Patients with locally advanced disease (stage IIIB) had a significantly better response rate (52%) than those with metastatic disease (25%) (P < 0.01). In 76 out of 110 (69%) patients, with tumour-related symptoms including 24 out of 31 patients (78%) with locally advanced disease, symptoms completely disappeared or substantially improved. In only 15 patients (14%) did symptoms progress during treatment. Symptomatic improvement was achieved after one course of chemotherapy in 61% and after two courses in 96% of responding patients. The schedule was well tolerated. Only 19% developed WHO grade 3/4 nausea/vomiting, and only 3% developed significant alopecia. Other toxicities were minimal. MVP is a pragmatic inexpensive chemotherapy regimen that offers useful symptom palliation in patients with advanced NSCLC and merits a 1-2 course therapeutic trial in such patients. The schedule should also be assessed as primary (neoadjuvant) chemotherapy before radical radiotherapy for locally advanced NSCLC in a randomised trial.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N4bc3277b52f64d37a53a26843902ea6c
57 N687d6ab694064d26bd40749aa50344a3
58 sg:journal.1017082
59 schema:name Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
60 schema:pagination 366
61 schema:productId N35e4579752b74619b739f21f13894107
62 N62b5f33e7b9740b7853e66e3b008f082
63 N73d74104aedc4c97bf12ba6576670ded
64 N7ae4049015ca4be1a1818ec69962eded
65 Nd8ef0c38d96b46ab8e8865c128a37bd2
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039124507
67 https://doi.org/10.1038/bjc.1995.74
68 schema:sdDatePublished 2019-04-11T11:55
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N7083287c648f4199bd73642e8faacea0
71 schema:url https://www.nature.com/articles/bjc199574
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N113b1a621b584250aa24218b7e59c506 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Female
77 rdf:type schema:DefinedTerm
78 N13ebfc5c5d3c4b47adae3c03ad9d8453 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Quality of Life
80 rdf:type schema:DefinedTerm
81 N2bccdd607c4b4abcafd11fb0fd7f92c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Mitomycins
83 rdf:type schema:DefinedTerm
84 N35e4579752b74619b739f21f13894107 schema:name pubmed_id
85 schema:value 7530988
86 rdf:type schema:PropertyValue
87 N399ec8867562470d96eae254da142444 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Survival Analysis
89 rdf:type schema:DefinedTerm
90 N4233f395b7c642eea1f5367adf1ac47f rdf:first sg:person.01222317235.09
91 rdf:rest Nbd0eef5a0a9d4da4ad5656d8233f72a8
92 N46b343b1d6a4483c9ce352fa457e6ff6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N4bc3277b52f64d37a53a26843902ea6c schema:volumeNumber 71
96 rdf:type schema:PublicationVolume
97 N62b5f33e7b9740b7853e66e3b008f082 schema:name nlm_unique_id
98 schema:value 0370635
99 rdf:type schema:PropertyValue
100 N64571c07d8e841fb8baa4bc163b1a972 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Treatment Outcome
102 rdf:type schema:DefinedTerm
103 N687d6ab694064d26bd40749aa50344a3 schema:issueNumber 2
104 rdf:type schema:PublicationIssue
105 N7083287c648f4199bd73642e8faacea0 schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N73d74104aedc4c97bf12ba6576670ded schema:name dimensions_id
108 schema:value pub.1039124507
109 rdf:type schema:PropertyValue
110 N787218321954447ea716d60133cdd42e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Lung Neoplasms
112 rdf:type schema:DefinedTerm
113 N7ae4049015ca4be1a1818ec69962eded schema:name doi
114 schema:value 10.1038/bjc.1995.74
115 rdf:type schema:PropertyValue
116 N83552de71a564812b9bb80b7853ec280 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Vomiting
118 rdf:type schema:DefinedTerm
119 N89830eee316d4de5b8b1c9f9413e68c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Aged
121 rdf:type schema:DefinedTerm
122 N8d632052c93e466188e34db4df6fbfa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hematologic Diseases
124 rdf:type schema:DefinedTerm
125 N8f6e73efe50543edafc6b68d1d48ca80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Adult
127 rdf:type schema:DefinedTerm
128 N93b2c79b234147cfbb71945bed71a925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Nausea
130 rdf:type schema:DefinedTerm
131 N9ee5a200ea9444048309f577a8ebd259 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Carcinoma, Non-Small-Cell Lung
133 rdf:type schema:DefinedTerm
134 Na1c0568db4284ec3ac879dcbe40d723d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 Na5407793803047c5aca48647d3102cf0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Alopecia
139 rdf:type schema:DefinedTerm
140 Nadb6a5b59c594422a2fa01f3285c4220 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Palliative Care
142 rdf:type schema:DefinedTerm
143 Nb06e5697b09048908f2145022c2aa7ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Combined Modality Therapy
145 rdf:type schema:DefinedTerm
146 Nbd0eef5a0a9d4da4ad5656d8233f72a8 rdf:first sg:person.016301514162.37
147 rdf:rest Ne3b921b26838409d99cf8b55dbeb7e94
148 Nbead803bb67b47c49e4e03ee7f9a65a9 rdf:first sg:person.01203740575.36
149 rdf:rest Nfa9dd982194547c092178cfe5802cc24
150 Nce5ab3e5a5ec4d78958ea676cf62963c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Middle Aged
152 rdf:type schema:DefinedTerm
153 Nd6fd0d7c1ecb4e089643f3419bcad3bc rdf:first sg:person.0762233040.78
154 rdf:rest rdf:nil
155 Nd8ef0c38d96b46ab8e8865c128a37bd2 schema:name readcube_id
156 schema:value ba5e9711020e195ce2e7b7f819c670085e111a1c2976675d4f6d0525ff9a8561
157 rdf:type schema:PropertyValue
158 Ndbecfca17de440e5acc4357a8f8aab0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Antineoplastic Combined Chemotherapy Protocols
160 rdf:type schema:DefinedTerm
161 Ne3b921b26838409d99cf8b55dbeb7e94 rdf:first sg:person.01203477301.58
162 rdf:rest Nbead803bb67b47c49e4e03ee7f9a65a9
163 Ne7c14b33ee874a038b3667641be7c519 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Vinblastine
165 rdf:type schema:DefinedTerm
166 Nf62e27b0a5bb46c79664d7cfa492cae6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Cisplatin
168 rdf:type schema:DefinedTerm
169 Nf9c895f9feeb4c48a77e08f2c604c944 rdf:first sg:person.016652536532.25
170 rdf:rest Nd6fd0d7c1ecb4e089643f3419bcad3bc
171 Nfa9dd982194547c092178cfe5802cc24 rdf:first sg:person.01116057764.83
172 rdf:rest Nf9c895f9feeb4c48a77e08f2c604c944
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
177 schema:name Oncology and Carcinogenesis
178 rdf:type schema:DefinedTerm
179 sg:journal.1017082 schema:issn 0007-0920
180 1532-1827
181 schema:name British Journal of Cancer
182 rdf:type schema:Periodical
183 sg:person.01116057764.83 schema:familyName Talbot
184 schema:givenName D C
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116057764.83
186 rdf:type schema:Person
187 sg:person.01203477301.58 schema:familyName Hardy
188 schema:givenName J R
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203477301.58
190 rdf:type schema:Person
191 sg:person.01203740575.36 schema:familyName Nicolson
192 schema:givenName M C
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203740575.36
194 rdf:type schema:Person
195 sg:person.01222317235.09 schema:affiliation https://www.grid.ac/institutes/grid.424926.f
196 schema:familyName Ellis
197 schema:givenName P A
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222317235.09
199 rdf:type schema:Person
200 sg:person.016301514162.37 schema:familyName Smith
201 schema:givenName I E
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016301514162.37
203 rdf:type schema:Person
204 sg:person.016652536532.25 schema:familyName Ashley
205 schema:givenName S E
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016652536532.25
207 rdf:type schema:Person
208 sg:person.0762233040.78 schema:familyName Priest
209 schema:givenName K
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762233040.78
211 rdf:type schema:Person
212 sg:pub.10.1038/bjc.1988.219 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001336530
213 https://doi.org/10.1038/bjc.1988.219
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/bjc.1989.355 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031243548
216 https://doi.org/10.1038/bjc.1989.355
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/bjc.1990.135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000556360
219 https://doi.org/10.1038/bjc.1990.135
220 rdf:type schema:CreativeWork
221 https://app.dimensions.ai/details/publication/pub.1079510178 schema:CreativeWork
222 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049278910
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1002/1097-0142(19820901)50:5<845::aid-cncr2820500507>3.0.co;2-s schema:sameAs https://app.dimensions.ai/details/publication/pub.1046751381
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051988897
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1002/1097-0142(19910515)67:10<2443::aid-cncr2820671008>3.0.co;2-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1008273687
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/0140-6736(93)91882-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1024077091
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/0169-5002(91)90279-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1011284989
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/0169-5002(93)90173-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1020528345
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1056/nejm199010043231403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016764914
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1093/jnci/83.6.417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059817056
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1093/jnci/85.10.794 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059817925
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1097/00000421-198810000-00012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028675398
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1200/jco.1986.4.1.14 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079793348
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.1986.4.12.1780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079511932
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.1988.6.4.633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079416239
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1200/jco.1990.8.5.886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078398349
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1200/jco.1990.8.8.1301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078408611
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1378/chest.89.4_supplement.225s schema:sameAs https://app.dimensions.ai/details/publication/pub.1051695750
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1378/chest.90.2.229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026608030
259 rdf:type schema:CreativeWork
260 https://doi.org/10.7326/0003-4819-115-9-681 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073696110
261 rdf:type schema:CreativeWork
262 https://doi.org/10.7326/0003-4819-95-4-414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073738990
263 rdf:type schema:CreativeWork
264 https://www.grid.ac/institutes/grid.424926.f schema:alternateName Royal Marsden Hospital
265 schema:name Lung Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...